Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain
NCT00881881 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2009-04-15
Summary
This is an epidemiological, multicenter, retrospective study to analyze the management of rheumatoid arthritis (RA) in usual clinical practice in Spain. Two groups of patients will be analyzed: individuals who have had RA for two years or less (the "early RA" group) and individuals who have had RA for more than 2 years and who currently meet the ACR criteria for RA (the "established RA" group).
Conditions
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2007-04-30
- Completion
- 2007-04-30
More Related Trials
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France
NCT02927509 ·Status: COMPLETED
-
Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
NCT02094326 ·Status: COMPLETED
-
An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy
NCT01664117 ·Status: COMPLETED
-
Long-term Experience With Abatacept SC in Routine Clinical Practice
NCT02090556 ·Status: COMPLETED
-
A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment
NCT03828045 ·Status: COMPLETED
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Very Early Versus Delayed Etanercept in Patients With RA
NCT02433184 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)
NCT00794118 ·Status: COMPLETED
-
Reduced Ultrasound Counts in Rheumatoid Arthritis
NCT02389283 ·Status: UNKNOWN
-
A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
NCT00767325 ·Status: COMPLETED ·Phase: PHASE3
-
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
NCT04343378 ·Status: COMPLETED
-
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
NCT00267852 ·Status: COMPLETED
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
NCT00848354 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries
NCT02632890 ·Status: COMPLETED
-
A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis
NCT05891600 ·Status: TERMINATED
-
Rheumatoid Arthritis Synovial Tissue Biopsy Study
NCT07000890 ·Status: COMPLETED ·Phase: NA
-
Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis
NCT02008266 ·Status: COMPLETED
-
Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis
NCT00596206 ·Status: COMPLETED ·Phase: PHASE3
-
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513 ·Status: NOT_YET_RECRUITING
-
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
NCT01083160 ·Status: TERMINATED
-
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
NCT00414661 ·Status: COMPLETED
-
Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
NCT00565409 ·Status: COMPLETED ·Phase: PHASE4